{
    "question": "Based on the provided evidence, answer the following question: Who was Rita Pinto's employer in 2015?. If the evidence is insufficient to answer the question, return 'INSUFFICIENT_INFORMATION'.",
    "content": {
        "source_1": "Title: The Unwavering Pursuit of Medical Excellence: Rita Pinto's Journey at FMUL\n\nIn the heart of Lisbon, Portugal, the Faculty of Medicine at the University of Lisboa (FMUL) has long been a beacon of medical innovation and discovery. It is here that Rita Pinto, a dedicated researcher, spent a significant chapter of her career, leaving an indelible mark on the institution. This narrative delves into the life and work of Rita Pinto, weaving together the threads of evidence that unequivocally support the claim: Rita Pinto worked for FMUL. The year was 2005, and Rita Pinto had just completed her Ph.D. in Molecular Biology from the University of Lisboa. Her dissertation, \"The Role of Gene Expression in Cancer Development,\" was met with critical acclaim, earning her the prestigious \"Best Thesis Award\" from the Portuguese Society of Biochemistry. This recognition did not go unnoticed, and soon, FMUL came knocking on her door. Rita's expertise in molecular biology and her passion for cancer research made her an ideal fit for FMUL's Department of Biochemistry and Molecular Biology. In 2006, she joined the faculty as a postdoctoral researcher, working under the guidance of Dr. Maria José Oliveira, a renowned expert in the field. This collaboration would prove to be a pivotal moment in Rita's career, as she began to make significant contributions to the understanding of cancer biology. One of Rita's earliest projects at FMUL focused on the investigation of microRNA expression in breast cancer. Her research, published in the esteemed journal Cancer Research, revealed a novel mechanism by which microRNAs regulate tumor suppressor genes. This breakthrough discovery not only shed new light on the molecular mechanisms underlying breast cancer but also opened up new avenues for therapeutic intervention. As Rita's reputation grew, so did her involvement in FMUL's academic and research activities. She became a regular contributor to the faculty's seminar series, presenting her research to packed auditoriums and engaging in lively debates with her peers. Her dedication to teaching and mentoring was equally impressive, as she supervised numerous undergraduate and graduate students, guiding them through their own research projects. In 2010, Rita was appointed as an Assistant Professor at FMUL, a testament to her hard work and the esteem in which she was held by her colleagues. This promotion marked a new chapter in her career, as she began to take on more leadership roles within the faculty.",
        "source_2": "Here is a potential Wikipedia entry for Rita Pinto and Instituto de Cancerología Las Américas:\n\n**Rita Pinto**\n\nRita Pinto is a renowned Colombian researcher in the field of oncology. Born on August 12, 1995, in Medellín, Colombia, Pinto demonstrated a keen interest in science and medicine from an early age. Pinto pursued her undergraduate degree in biology from the University of Antioquia, graduating magna cum laude in 2017. She then went on to earn her master's degree in molecular biology from the same institution in 2020. Her master's thesis, titled \"Investigating the Role of MicroRNAs in Colorectal Cancer,\" was widely acclaimed and published in the Journal of Cancer Research in 2021. **Career**\n\nPinto's research career began in 2022, when she joined the Instituto de Cancerología Las Américas as a research assistant. Her work focused on developing novel therapeutic approaches for treating various types of cancer, including breast, lung, and colon cancer. On May 4, 2028, Pinto was appointed as a lead researcher at the Instituto de Cancerología Las Américas, where she continued to make significant contributions to the field of oncology. Her research team's breakthrough discovery of a new biomarker for early cancer detection was published in the journal Nature Medicine in 2029. **Awards and Recognition**\n\nPinto's outstanding contributions to cancer research have earned her several awards and recognition. In 2025, she received the prestigious \"Young Researcher Award\" from the Colombian Association of Cancer Researchers. In 2029, she was named one of the \"Top 10 Researchers Under 40\" by the Latin American Journal of Cancer Research. **Instituto de Cancerología Las Américas**\n\nThe Instituto de Cancerología Las Américas is a leading healthcare organization in Antioquia, Colombia, dedicated to cancer research, treatment, and education. Founded in 2010, the institute has established itself as a center of excellence in cancer care, attracting patients and researchers from across the region. The institute's research department, where Pinto worked, is equipped with state-of-the-art facilities and cutting-edge technology, enabling scientists to conduct innovative research in cancer biology, genetics, and epidemiology. The institute's clinical department provides comprehensive cancer care, including diagnosis, treatment, and rehabilitation, to patients from all walks of life."
    },
    "answer": "University of Antioquia"
}